Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle-Reference-Cited by-同舟云学术

Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle

Published:2015-01-02 Issue:1 Volume:7 Page:42-52
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Zhang Kathy¹,Geddie Melissa L¹,Kohli Neeraj¹,Kornaga Tad¹,Kirpotin Dmitri B¹,Jiao Yang¹,Rennard Rachel¹,Drummond Daryl C¹,Nielsen Ulrik B¹,Xu Lihui¹,Lugovskoy Alexey A¹

Affiliation:

1. Merrimack Pharmaceuticals, Inc.; Cambridge, MA USA

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.4161/19420862.2014.985933

Reference50 articles.

1. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development

2. Liposomal drug delivery systems: From concept to clinical applications

3. Phase I Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Advanced Breast Cancer

4. Liposomal Doxorubicin and nab-Paclitaxel: Nanoparticle Cancer Chemotherapy in Current Clinical Use

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-09-11

2. Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers;mAbs;2024-07-24

3. Nano-differential scanning fluorimetry as a tool for the assessment of refolded antibody fragments: A case study for anti-Pfs25 single-chain antibodies;Biochemical Engineering Journal;2024-06

4. Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma;Cancer Immunology, Immunotherapy;2024-04-17

5. Refolding and characterization of a diabody against Pfs25, a vaccine candidate of Plasmodium falciparum;Analytical Biochemistry;2022-10